Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Trial for Evaluation of Vermillion's Blood Test to Predict the Probability of Peripheral Artery Disease

NCT01336426 is registered in ClinicalTrials.gov with Vermillion, Inc. as lead sponsor.

NCT NCT01336426
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01336426 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Trial for Evaluation of Vermillion's Blood Test to Predict the Probability of Peripheral Artery Disease
Lead sponsor
Vermillion, Inc.
Phase
Observational
Overall status
Completed
Start date
March 31, 2011
Completion date
August 31, 2011
Enrollment
1,033 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

peripheral artery disease